We next utilized published RNAseq data to examine levels of gene expression of HER2, NHERF1 and Ezrin in HER2-positive human DCIS as compared to levels of expression of the same mRNAs in normal breast tissue. The gene discussed is NHERF1; the disease is ductal breast carcinoma in situ.